search
Back to results

Implicit and Explicit Assessment of Suicide Risk (MIERIS)

Primary Purpose

Implicit Association Test, Suicide, Prevention, Suicide

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Implicit Attitude Test
Sponsored by
Centre Hospitalier Universitaire, Amiens
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Implicit Association Test focused on measuring Implicit association test, Suicide, Prevention, Suicide, suicide risk factor

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Person presenting to emergencies for psychiatric reasons Adult person Free and informed consent signed Person speaking and writing French fluently Exclusion Criteria: Neurological disorders or major cognitive deterioration: presence of confusion Acute psychotic decompensation Troubled acute behavior Abuse Impregnation of a toxic substance and / or drug impairing cognitive functions at the time of assessment Adult under protective measure.

Sites / Locations

  • Centre Hospitalier Universitaire d'AmiensRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

Patient with explicit suicidal ideation and suicide attempt

Patient with explicit suicidal ideation without suicide attempt

Patient without explicit suicidal ideation

Arm Description

Outcomes

Primary Outcome Measures

Variation of IAT score betwenn the 3 groups
IAT is Implicit Attitude Test The IAT is a brief computer-administered test that uses people's reaction times when classifying semantic stimuli to measure the automatic mental associations they hold about various topics, in this case, life and death/suicide. The death/suicide IAT will be administered and scored in keeping with standard IAT procedures. Response latencies for all trials were recorded and analyzed using the standard IAT scoring algorithm.

Secondary Outcome Measures

Full Information

First Posted
June 6, 2023
Last Updated
June 20, 2023
Sponsor
Centre Hospitalier Universitaire, Amiens
Collaborators
Centre Hospitalier Pinel d'Amiens
search

1. Study Identification

Unique Protocol Identification Number
NCT05903469
Brief Title
Implicit and Explicit Assessment of Suicide Risk
Acronym
MIERIS
Official Title
Implicit and Explicit Assessment of Suicide Risk
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 28, 2022 (Actual)
Primary Completion Date
March 2024 (Anticipated)
Study Completion Date
January 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire, Amiens
Collaborators
Centre Hospitalier Pinel d'Amiens

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In 2007 Nock & Banaji developed a so-called implicit suicide risk measurement using a computer tool: the Implicit Association Test (IAT). This measurement, associated with traditional evaluations, makes it possible to better predict suicidal recurrence. In 2020, the Poitiers team of Tello was able to replicate these results on a French population. However, although a high IAT score predicts the onset of suicide at 1 year, there is no data on how this score changes over time nor even data concerning the measure's ability to differentiate a population with explicit suicidal ideation from a population without explicit suicidal ideation. The investigators therefore seek to demonstrate an evolution of implicit suicidal ideation over time by replicating the measurement at inclusion, at 6 months and at 12 months, for different patient profiles: Suicidal ideation vs No suicidal ideation and suicide attempt vs no suicide attempt. Patients will be recruited from the emergency-unit of CHU Amiens-Picardie and will take the suicide-IAT as well as various questionnaires.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Implicit Association Test, Suicide, Prevention, Suicide, Suicide Risk Factor
Keywords
Implicit association test, Suicide, Prevention, Suicide, suicide risk factor

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
180 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Patient with explicit suicidal ideation and suicide attempt
Arm Type
Experimental
Arm Title
Patient with explicit suicidal ideation without suicide attempt
Arm Type
Experimental
Arm Title
Patient without explicit suicidal ideation
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
Implicit Attitude Test
Intervention Description
The IAT (Implicit Attitude Test) is a method of indirectly measuring the relative strength of associations between different concepts stored in memory based on reaction times on computer. The general idea behind this measure is that an individual will be much faster to categorize an object into a predetermined category, if this categorization is consistent with their own way of processing information.
Primary Outcome Measure Information:
Title
Variation of IAT score betwenn the 3 groups
Description
IAT is Implicit Attitude Test The IAT is a brief computer-administered test that uses people's reaction times when classifying semantic stimuli to measure the automatic mental associations they hold about various topics, in this case, life and death/suicide. The death/suicide IAT will be administered and scored in keeping with standard IAT procedures. Response latencies for all trials were recorded and analyzed using the standard IAT scoring algorithm.
Time Frame
one year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Person presenting to emergencies for psychiatric reasons Adult person Free and informed consent signed Person speaking and writing French fluently Exclusion Criteria: Neurological disorders or major cognitive deterioration: presence of confusion Acute psychotic decompensation Troubled acute behavior Abuse Impregnation of a toxic substance and / or drug impairing cognitive functions at the time of assessment Adult under protective measure.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jérôme Thilliez, MD
Phone
03.22.66.82.90
Email
thilliez.jerome@chu-amiens.fr
Facility Information:
Facility Name
Centre Hospitalier Universitaire d'Amiens
City
Amiens
State/Province
Picardie
ZIP/Postal Code
80000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jérôme Thilliez, MD
Phone
03.22.66.82.90
Email
thilliez.jerome@chu-amiens.fr

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Implicit and Explicit Assessment of Suicide Risk

We'll reach out to this number within 24 hrs